Cell Isolation and Organ Function Core
Cell Isolation and Organ Function Core
批准号:
10200077
负责人:
Elizabeth O Harrington
金额:
$29.52万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-20 至 2023-05-31
关键词:
Adult Respiratory Distress SyndromeAtherosclerosisBiologyBlood VesselsBronchopulmonary DysplasiaBusinessesCardiac MyocytesCardiac developmentCardiopulmonaryCell SeparationCell physiologyCellsCenters of Research ExcellenceCongenital Heart DefectsConsultationsCultured CellsDataDevelopmentDisease ProgressionEndothelial CellsEndotheliumEnsureExperimental DesignsFibroblastsFunctional disorderGoalsHeartHeart DiseasesImageImage AnalysisInjuryInterruptionLasersLeadLungLung diseasesMeasurementMutationOrganPathogenesisPhasePhenotypeProceduresProcessProductivityPulmonary HypertensionReproducibilityResearchResearch PersonnelResearch Project GrantsResourcesRhode IslandServicesStructureSystemTechnologyTissuesTranslatingVascular DiseasesVascular remodelingangiogenesiscell typegenetic manipulationheart functionidiopathic pulmonary fibrosisin vivoinjury and repairinstrumentationmorphometrynovelpulmonary functionrepairedresponseresponse to injuryskillstooltranscription factorvascular injury
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The central goals of the CardioPulmonary Vascular Biology (CPVB) Center for Biomedical Research
Excellence (COBRE) are to understand basic mechanisms of vascular disease pathogenesis and to translate
these findings into treatments for heart and lung diseases. Vascular injury, repair, and remodeling are critical
to the pathogenesis of the conditions studied in Phase II projects--bronchopulmonary dysplasia (BPD),
atherosclerosis, idiopathic pulmonary fibrosis (IPF), pulmonary hypertension, and acute respiratory distress
syndrome (ARDS). Cardiac development and remodeling in response to injury similarly include both adaptive
and maladaptive responses. Dysfunction of angiogenesis, the reparative response of the endothelium to injury,
and aberrant vascular remodeling have been proposed to occur in ARDS, BPD, IPF and other heart and lung
conditions. In addition, some congenital heart defects result from mutations in transcription factors that
regulate cardiomyocyte and endothelial cell (EC) function in development. Thus, an increased understanding
of the mechanisms regulating the adaptation of the vasculature to injury and repair may lead to unique
approaches to interrupt disease progression or to promote or enhance cardiopulmonary vascular repair.
During Phase I the Cell/Organ Core developed centralized systems for cell isolations and organ function
measurements and provided reproducible and accurate data for COBRE Projects. Additional services
underway to enhance the Cell/Organ Core capabilities for the vascular biologists in Rhode Island and Phase II
investigators are expansion of i) type of cell isolations; ii) immunohistochemical analyses; iii) EC function of
primary isolates; iv) laser Doppler imaging; and v) in vivo angiogenesis. The Core will offer consultation on
experimental design, provide cutting edge technological approaches, generate and analyze data, and serve as
a resource for CPVB COBRE investigators and others in Rhode Island. The Core will also develop a business
plan for financial stability of existing services and identify novel business or collaborative opportunities to
ensure sustainability of the CPVB core. The overall goal of the Cell/Organ Core is to facilitate the scientific
objectives and technical repertoire of the Project and Pilot Investigators by the following specific aims. (1)
Enhance the productivity of CPVB COBRE research projects by offering reproducible, economical, and high
quality i) cell isolation, propagation, phenotypic characterization and functional assessment ii) assessment of
heart, lung, vessel structure and function and angiogenesis, and (iii) transient gene manipulation in vivo. (2)
Acquire, establish, and disseminate technologies and instrumentation to provide state of the art research tools
for vascular biology research in Rhode Island. (3) Establish processes and procedures that support the
sustainability of the Cell/Organ Core. The CPVB COBRE Cell/Organ Core will support vascular biology
research, including new investigators, projects, technical approaches and ideas that enhance the impact of
research in Rhode Island.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
“Phenotyping Heart Failure with Preserved Ejection Fraction Using Non- Invasive Biomarkers
-
批准号:10624557
-
项目类别:
-
资助金额:$19.13万
-
财政年份:2022
-
负责人:Elizabeth O Harrington
-
依托单位:
Uncoupling of IL-1 beta and VEGF-A Crosstalk Contributes to Impaired Arteriogenesis Response to Ischemia in Chronic Diabetes Mellitus
-
批准号:10549633
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2021
-
负责人:Elizabeth O Harrington
-
依托单位:
Brown Respiratory Research Training Program
-
批准号:10270460
-
项目类别:
-
资助金额:$63.73万
-
财政年份:2017
-
负责人:Elizabeth O Harrington
-
依托单位:
Brown Respiratory Research Training Program
-
批准号:10581473
-
项目类别:
-
资助金额:$65.11万
-
财政年份:2017
-
负责人:Elizabeth O Harrington
-
依托单位:
The Role of NPR-C In Modulation Of Acute Lung Injury
-
批准号:9235305
-
项目类别:
-
资助金额:$30.25万
-
财政年份:2015
-
负责人:Elizabeth O Harrington
-
依托单位:
Uncoupling of IL-1 beta and VEGF-A Crosstalk Contributes to Impaired Arteriogenesis Response to Ischemia in Chronic Diabetes Mellitus
-
批准号:10579818
-
项目类别:
-
资助金额:$34.98万
-
财政年份:2013
-
负责人:Elizabeth O Harrington
-
依托单位:
Cell Isolation and Organ Function Core
-
批准号:10437830
-
项目类别:
-
资助金额:$32.49万
-
财政年份:2013
-
负责人:Elizabeth O Harrington
-
依托单位:
Alpert Medical School Summer Research Program
-
批准号:10117082
-
项目类别:
-
资助金额:$7.3万
-
财政年份:2009
-
负责人:Elizabeth O Harrington
-
依托单位:
Alpert Medical School Summer Research Program
-
批准号:8794651
-
项目类别:
-
资助金额:$3.68万
-
财政年份:2009
-
负责人:Elizabeth O Harrington
-
依托单位:
Alpert Medical School Summer Research Program
-
批准号:9180718
-
项目类别:
-
资助金额:$4.54万
-
财政年份:2009
-
负责人:Elizabeth O Harrington
-
依托单位:
Alpert Medical School Summer Research Program
-
批准号:8968846
-
项目类别:
-
资助金额:$4.47万
-
财政年份:2009
-
负责人:Elizabeth O Harrington
-
依托单位:
Endothelial Barrier Function Modulation by PKCdelta
-
批准号:6773804
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2001
-
负责人:Elizabeth O Harrington
-
依托单位:
Endothelial Barrier Function Modulation by PKCDelta
-
批准号:7342899
-
项目类别:
-
资助金额:$39.03万
-
财政年份:2001
-
负责人:Elizabeth O Harrington
-
依托单位:
Endothelial Barrier Function Modulation by PKCdelta
-
批准号:6359745
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2001
-
负责人:Elizabeth O Harrington
-
依托单位:
Endothelial Barrier Function Modulation by PKCDelta
-
批准号:8018619
-
项目类别:
-
资助金额:$38.97万
-
财政年份:2001
-
负责人:Elizabeth O Harrington
-
依托单位:
Endothelial Barrier Function Modulation by PKCdelta
-
批准号:6603960
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2001
-
负责人:Elizabeth O Harrington
-
依托单位:
Endothelial Barrier Function Modulation by PKCdelta
-
批准号:6527922
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2001
-
负责人:Elizabeth O Harrington
-
依托单位:
Endothelial Barrier Function Modulation by PKCDelta
-
批准号:7567554
-
项目类别:
-
资助金额:$39.01万
-
财政年份:2001
-
负责人:Elizabeth O Harrington
-
依托单位:
Endothelial Barrier Function Modulation by PKCDelta
-
批准号:7755372
-
项目类别:
-
资助金额:$38.99万
-
财政年份:2001
-
负责人:Elizabeth O Harrington
-
依托单位:
Endothelial Barrier Function Modulation by PKCDelta
-
批准号:7212616
-
项目类别:
-
资助金额:$38.91万
-
财政年份:2001
-
负责人:Elizabeth O Harrington
-
依托单位:
海外基金